FIGURE 5.
Deviation of observed lateral diffusion from predictions for membrane homogeneity and derived model of membrane heterogeneity. A, observed diffusion coefficients versus predictions for homogeneous lipid. The bar graph show the ratio of diffusion coefficients between our observation and the theoretical prediction based on homogenous lipid membrane calculated as described under “Experimental Procedures.” The treatments (additions to oxygenated Ringer's solution with 10 mm glucose, except as noted) for each sample were: Gαt, cholesterol added (α-toxin/MβCD/cholesterol); Gαt (no additions or α-toxin/ATP/GTPγS); Rho2-Gαβγt (2-DG/sodium azide, no glucose); Gαβγt (hydroxylamine); Rho2 (rhodospin-EGFP transgenics; no additions); Gαt, cholesterol depleted (α-toxin/MβCD); Rho2-Gαβγt, cholesterol depleted (α-toxin/MβCD/2-DG/sodium azide, no glucose); Gαβγt, cholesterol depleted (α-toxin/MβCD/hydroxylamine); and Rho2, cholesterol depleted (rhodospin-EGFP transgenics, α-toxin/MβCD). Unless otherwise indicated, all measurements used Gαt-EGFP transgenic tadpoles. B, proposed model of disk membrane heterogeneity and diffusion. Based on our findings, the following sequence of events is proposed. In the dark, and immediately after photoexcitation of rhodopsin, both rhodopsin and GDP-Gαβγt diffuse freely in a bulk lipid phase with relatively low effective viscosity. Upon binding of GDP-bound Gαβγt to light-activated rhodopsin (R*), the complex moves from bulk lipid into microdomains (or microdomains assemble around the complex), which may facilitate the conformational changes necessary for GDP-GTP exchange and dissociation of activated GTP-Gαt from R*. GTP-Gαt remains associated with microdomains while in the active state.